Combating drug shortages in China: surveillance warning and practice standardization

被引：10

作者：

Shi, Yin ^{[1
,2
,3
]}

Yang, Ping ^{[1
,2
,3
]}

Li, Xiangping ^{[1
,2
,3
]}

Lv, Jinfeng ^{[1
,2
,3
]}

Yin, Tao ^{[1
,2
,3
]}

Gong, Zhicheng ^{[1
,2
,3
]}

Sun, Shusen ^{[1
,2
,3
,4
]}

Zhou, Boting ^{[1
,2
,3
]}

机构：

[1] Cent South Univ, Dept Pharm, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China

[2] Hunan Drug Shortage Surveillance & Early Warning, Changsha 410008, Hunan, Peoples R China

[3] Hunan Inst Pharm Practice & Clin Res, Changsha 410008, Hunan, Peoples R China

[4] Western New England Univ, Dept Pharm Practice, Coll Pharm & Hlth Sci, Springfield, MA 01119 USA

来源：

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 02期

关键词：

China; Drug shortages; Early warning; Practice standardization; Surveillance;

D O I：

10.1007/s11096-020-00987-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Like other countries, China has been experiencing drug shortages during the past years, including drugs on the National Essential Medicine List and emergency drugs. Drug shortages have raised public concerns in China and have severe impacts on all stakeholders in the supply chain, especially patients and hospitals. Recently, Chinese governments have ramped up several measures to ensure a steady supply of essential and first-aid drugs. In this commentary, we share our experiences of addressing drug shortages at Hunan Province, central China. We focus on the establishment of a provincial drug shortage monitoring center, and the Center's efforts to standardize practices on the management of drug shortages and identify therapeutic alternatives for drugs in short supply based on international best practices.

引用

页码：309 / 314

页数：6

共 7 条

[1]

[樊进武 Fan Jinwu], 2018, [中国新药杂志, Chinese Journal New Drugs], V27, P1964

[2]

Fox Erin R, 2018, Am J Health Syst Pharm, V75, P1742, DOI 10.2146/ajhp180441

[3] Shortages of medicines: a complex global challenge [J].